NCT06830109View on ClinicalTrials.gov

Nasal Obstruction With Oxymetazoline and Corticosteroids

PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 15, 2024

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2026

Conditions
Nasal Obstruction
Interventions
DRUG

Oxymetazoline Nasal Spray

Intra-nasal alpha-adrenergic agonist and vasoconstrictor that is available over-the-counter (OTC)

DRUG

Budesonide nasal spray

Intranasal corticosteroid that is available over-the-counter (OTC)

Trial Locations (1)

63110

RECRUITING

Washington University, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER